Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pitolisant for residual excessive daytime sleepiness in obstructive sleep apnoea despite nCPAP
2009-017248-14Phase 3Completed
- Sponsor
- Bioprojet
- Start
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of pitolisant in Excessive Daytime Sleepiness (EDS) (4 arms), sponsored by Bioprojet. Started Nov 2010; status: completed.
02
Drugs
pitolisant
03
Conditions
Excessive Daytime Sleepiness (EDS)
Beyond the preview
Go deeper on 2009-017248-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017248-14.